A citation-based method for searching scientific literature


List of co-cited articles
110 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biology of human sodium glucose transporters.
Ernest M Wright, Donald D F Loo, Bruce A Hirayama. Physiol. Rev. 2011
573
60

Improved glycemic control in mice lacking Sglt1 and Sglt2.
David R Powell, Christopher M DaCosta, Jason Gay, Zhi-Ming Ding, Melinda Smith, Jennifer Greer, Deon Doree, Sabrina Jeter-Jones, Faika Mseeh, Lawrence A Rodriguez,[...]. Am. J. Physiol. Endocrinol. Metab. 2013
83
36

LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.
B Zambrowicz, J Freiman, P M Brown, K S Frazier, A Turnage, J Bronner, D Ruff, M Shadoan, P Banks, F Mseeh,[...]. Clin. Pharmacol. Ther. 2012
141
36

Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter.
E Turk, B Zabel, S Mundlos, J Dyer, E M Wright. Nature 1991
201
36

LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose.
David R Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K Shadoan, Arthur Sands, Brian Zambrowicz,[...]. J. Pharmacol. Exp. Ther. 2013
98
32

KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models.
Toshihide Shibazaki, Masaki Tomae, Yukiko Ishikawa-Takemura, Nobuhiko Fushimi, Fumiaki Itoh, Mitsuhiko Yamada, Masayuki Isaji. J. Pharmacol. Exp. Ther. 2012
45
28

Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes.
Brian Zambrowicz, Zhi-Ming Ding, Ike Ogbaa, Kenny Frazier, Phillip Banks, Anne Turnage, Joel Freiman, Melinda Smith, Dennis Ruff, Arthur Sands,[...]. Clin Ther 2013
50
28

Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.
Valentin Gorboulev, Annette Schürmann, Volker Vallon, Helmut Kipp, Alexander Jaschke, Dirk Klessen, Alexandra Friedrich, Stephan Scherneck, Timo Rieg, Robyn Cunard,[...]. Diabetes 2012
332
24

Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects.
Brian Zambrowicz, Ike Ogbaa, Kenny Frazier, Phillip Banks, Anne Turnage, Joel Freiman, Kristi A Boehm, Dennis Ruff, David Powell, Arthur Sands. Clin Ther 2013
40
24

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
Arthur T Sands, Brian P Zambrowicz, Julio Rosenstock, Pablo Lapuerta, Bruce W Bode, Satish K Garg, John B Buse, Phillip Banks, Rubina Heptulla, Marc Rendell,[...]. Diabetes Care 2015
106
24

I. Glucose galactose malabsorption.
E M Wright. Am. J. Physiol. 1998
62
20


Molecular basis for glucose-galactose malabsorption.
Ernest M Wright, Eric Turk, Martin G Martin. Cell Biochem. Biophys. 2002
65
20

Congenital glucose-galactose malabsorption: a novel deletion within the SLC5A1 gene.
L Vallaeys, S Van Biervliet, G De Bruyn, B Loeys, A S Moring, E Van Deynse, L Cornette. Eur. J. Pediatr. 2013
12
41

Effect of LX4211 on glucose homeostasis and body composition in preclinical models.
David R Powell, Christopher M DaCosta, Melinda Smith, Deon Doree, Angela Harris, Lindsey Buhring, William Heydorn, Amr Nouraldeen, Wendy Xiong, Padmaja Yalamanchili,[...]. J. Pharmacol. Exp. Ther. 2014
32
20

Expression cloning and cDNA sequencing of the Na+/glucose co-transporter.
M A Hediger, M J Coady, T S Ikeda, E M Wright. Nature 1987
612
20

LX4211 therapy reduces postprandial glucose levels in patients with type 2 diabetes mellitus and renal impairment despite low urinary glucose excretion.
Brian Zambrowicz, Pablo Lapuerta, Paul Strumph, Phillip Banks, Alan Wilson, Ike Ogbaa, Arthur Sands, David Powell. Clin Ther 2015
23
21

Bitterness of glucose/galactose: novel mutations in the SLC5A1 gene.
Ben Pode-Shakked, Orit Reish, Cigdem Aktuglu-Zeybek, Dafna Kesselman, Benjamin Dekel, Yoram Bujanover, Yair Anikster. J. Pediatr. Gastroenterol. Nutr. 2014
8
62

Gut hormone PYY(3-36) physiologically inhibits food intake.
Rachel L Batterham, Michael A Cowley, Caroline J Small, Herbert Herzog, Mark A Cohen, Catherine L Dakin, Alison M Wren, Audrey E Brynes, Malcolm J Low, Mohammad A Ghatei,[...]. Nature 2002
16

Carboxyl group-terminated polyamidoamine dendrimers bearing glucosides inhibit intestinal hexose transporter-mediated D-glucose uptake.
Shinji Sakuma, Yumi Teraoka, Tomokazu Sagawa, Yoshie Masaoka, Makoto Kataoka, Shinji Yamashita, Yoshiyuki Shirasaka, Ikumi Tamai, Yusuke Ikumi, Toshiyuki Kida,[...]. Eur J Pharm Biopharm 2010
10
40

A novel mutation of Na+/glucose cotransporter in a Turkish newborn with congenital glucose-galactose malabsorption.
Faysal Gok, Halil I Aydin, Ismail Kurt, Erdal Gokcay, Mari Maeda, Michihiro Kasahara. J. Pediatr. Gastroenterol. Nutr. 2005
9
44

Intestinal absorption in health and disease--sugars.
Ernest M Wright, Martín G Martín, Eric Turk. Best Pract Res Clin Gastroenterol 2003
111
16

Active sugar transport in health and disease.
E M Wright, B A Hirayama, D F Loo. J. Intern. Med. 2007
325
16

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes.
James F List, Vincent Woo, Enrique Morales, Weihua Tang, Fred T Fiedorek. Diabetes Care 2009
392
16

Expression of monosaccharide transporters in intestine of diabetic humans.
J Dyer, I S Wood, A Palejwala, A Ellis, S P Shirazi-Beechey. Am. J. Physiol. Gastrointest. Liver Physiol. 2002
158
16

Congenital glucose-galactose malabsorption: a descriptive study of clinical characteristics and outcome from Western Saudi Arabia.
Omar I Saadah, Sharifa A Alghamdi, Haifa H Sindi, Huda Alhunaitti, Yagoub Y Bin-Taleb, Bakr H Alhussaini. Arab J Gastroenterol 2014
7
57

Five Arab children with glucose-galactose malabsorption.
Asaad Assiri, Anjum Saeed, Abdulrehman Alnimri, Sarfaraz Ahmad, Elshazalay Saeed, Sajjad Jameel. Paediatr Int Child Health 2013
6
66

SLC5A1 Mutations in Saudi Arabian Patients With Congenital Glucose-Galactose Malabsorption.
Yasir Al-Suyufi, Khalid ALSaleem, Ali Al-Mehaidib, Mohammed Banemai, Wajeeh M Aldekhail, Abdulhakim Al-Muhandes, Manal Mohammed, Rabab Allam, Amani Jambi, Khushnooda Ramzan,[...]. J. Pediatr. Gastroenterol. Nutr. 2018
5
80

Mutant neurogenin-3 in congenital malabsorptive diarrhea.
Jiafang Wang, Galen Cortina, S Vincent Wu, Robert Tran, Jang-Hyeon Cho, Ming-Jer Tsai, Travis J Bailey, Milan Jamrich, Marvin E Ament, William R Treem,[...]. N. Engl. J. Med. 2006
165
12

Nephrocalcinosis in glucose-galactose malabsorption: nephrocalcinosis and proximal tubular dysfunction in a young infant with a novel mutation of SGLT1.
Ozlem Bekem Soylu, Ciğdem Ecevit, Serdar Altinöz, Aysel Aydoğan Oztürk, Ali Kemal Temizkan, Mari Maeda, Michihiro Kasahara. Eur. J. Pediatr. 2008
9
33

A glucose sensor hiding in a family of transporters.
Ana Diez-Sampedro, Bruce A Hirayama, Christina Osswald, Valentin Gorboulev, Katharina Baumgarten, Christopher Volk, Ernest M Wright, Hermann Koepsell. Proc. Natl. Acad. Sci. U.S.A. 2003
185
12

SGLT2 inhibition--a novel strategy for diabetes treatment.
Edward C Chao, Robert R Henry. Nat Rev Drug Discov 2010
329
12

Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members.
Jian Chen, Sandy Williams, Samantha Ho, Howard Loraine, Deborah Hagan, Jean M Whaley, John N Feder.  2010
126
12

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
12

Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.
David Polidori, Sue Sha, Sunder Mudaliar, Theodore P Ciaraldi, Atalanta Ghosh, Nicole Vaccaro, Kristin Farrell, Paul Rothenberg, Robert R Henry. Diabetes Care 2013
166
12


D28G mutation in congenital glucose-galactose malabsorption.
Hamid-Reza Kianifar, Saeed Talebi, Saeed Talebi, Jalil Tavakkol-Afshari, Mohammad Esmaili, Behrouz Davachi, Azam Brook. Arch Iran Med 2007
6
50

Nephrolithiasis in a child with glucose-galactose malabsorption.
Velibor Tasic, Nevenka Slaveska, Nenad Blau, René Santer. Pediatr. Nephrol. 2004
12
25

Nutrition management of congenital glucose-galactose malabsorption: a case study.
A Abad-Sinden, S Borowitz, R Meyers, J Sutphen. J Am Diet Assoc 1997
8
37

Glucose-galactose malabsorption with renal stones in a Saudi child.
A M Abdullah, M A Abdullah, M B Abdurrahman, M A al Husain. Ann Trop Paediatr 1992
13
23

Chronic diarrhoea caused by monosaccharide malabsorption.
B LINDQUIST, G W MEEUWISSE. Acta Paediatr 1962
61
12

Congenital selective malabsorption of glucose and galactose.
L Evans, E Grasset, M Heyman, A M Dumontier, J P Beau, J F Desjeux. J. Pediatr. Gastroenterol. Nutr. 1985
26
12

Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes.
Julio Rosenstock, Naresh Aggarwal, David Polidori, Yue Zhao, Deborah Arbit, Keith Usiskin, George Capuano, William Canovatchel. Diabetes Care 2012
282
12

A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes.
E Ferrannini, L Seman, E Seewaldt-Becker, S Hantel, S Pinnetti, H J Woerle. Diabetes Obes Metab 2013
120
12

Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, Maria Maione, Vesta Lai, Alana Lee, Nora M Fagan, Hans J Woerle, Odd Erik Johansen, Uli C Broedl,[...]. Circulation 2014
545
12

Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial.
Bruce A Perkins, David Z I Cherney, Helen Partridge, Nima Soleymanlou, Holly Tschirhart, Bernard Zinman, Nora M Fagan, Stefan Kaspers, Hans-Juergen Woerle, Uli C Broedl,[...]. Diabetes Care 2014
145
12


Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT1 and SGLT2, in patients with type 2 diabetes on metformin monotherapy.
Julio Rosenstock, William T Cefalu, Pablo Lapuerta, Brian Zambrowicz, Ike Ogbaa, Phillip Banks, Arthur Sands. Diabetes Care 2015
41
12

Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.
Robert R Henry, Julio Rosenstock, Steven Edelman, Sunder Mudaliar, Alexandros-Georgios Chalamandaris, Sreeneeranj Kasichayanula, Allyson Bogle, Nayyar Iqbal, James List, Steven C Griffen. Diabetes Care 2015
133
12

Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor.
Pablo Lapuerta, Brian Zambrowicz, Paul Strumph, Arthur Sands. Diab Vasc Dis Res 2015
52
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.